Morgan Stanley’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,150,771
| Closed | -$110M | – | 8296 |
|
2024
Q4 | $110M | Buy |
2,150,771
+989,513
| +85% | +$50.5M | 0.01% | 1182 |
|
2024
Q3 | $47.9M | Buy |
1,161,258
+40,519
| +4% | +$1.67M | ﹤0.01% | 1860 |
|
2024
Q2 | $54M | Sell |
1,120,739
-452,935
| -29% | -$21.8M | ﹤0.01% | 1696 |
|
2024
Q1 | $75.5M | Sell |
1,573,674
-290
| -0% | -$13.9K | 0.01% | 1388 |
|
2023
Q4 | $102M | Buy |
1,573,964
+669,515
| +74% | +$43.5M | ﹤0.01% | 1703 |
|
2023
Q3 | $59.2M | Sell |
904,449
-89,742
| -9% | -$5.87M | 0.01% | 1421 |
|
2023
Q2 | $57.8M | Sell |
994,191
-128,048
| -11% | -$7.44M | 0.01% | 1460 |
|
2023
Q1 | $69.3M | Sell |
1,122,239
-151,391
| -12% | -$9.35M | 0.01% | 1289 |
|
2022
Q4 | $81M | Buy |
1,273,630
+1,019,378
| +401% | +$64.8M | 0.01% | 1171 |
|
2022
Q3 | $18.5M | Sell |
254,252
-13,365
| -5% | -$971K | ﹤0.01% | 2273 |
|
2022
Q2 | $18.2M | Buy |
267,617
+80,288
| +43% | +$5.46M | ﹤0.01% | 2398 |
|
2022
Q1 | $17M | Buy |
187,329
+68,781
| +58% | +$6.23M | ﹤0.01% | 2293 |
|
2021
Q4 | $10.8M | Sell |
118,548
-57,772
| -33% | -$5.27M | ﹤0.01% | 2869 |
|
2021
Q3 | $14.3M | Sell |
176,320
-1,824
| -1% | -$148K | ﹤0.01% | 2478 |
|
2021
Q2 | $16.6M | Buy |
178,144
+82,802
| +87% | +$7.72M | ﹤0.01% | 2368 |
|
2021
Q1 | $10.2M | Sell |
95,342
-279,977
| -75% | -$30M | ﹤0.01% | 2625 |
|
2020
Q4 | $32.8M | Buy |
375,319
+343,952
| +1,097% | +$30M | 0.01% | 1412 |
|
2020
Q3 | $2.17M | Buy |
31,367
+23,536
| +301% | +$1.62M | ﹤0.01% | 3587 |
|
2020
Q2 | $380K | Buy |
+7,831
| New | +$380K | ﹤0.01% | 4746 |
|